Solutrol Extended-Release Technology
Solutrol is proprietary extended-release technology that uses a unique matrix to deliver Oxtellar XR evenly and at a controlled rate over a 24-hour period.1,2
Click on the video below for more information on how Solutrol technology works.
- Data on file. Supernus Pharmaceuticals, Inc. Rockville, MD.
- French JA, Baroldi P, Brittain ST, Johnson JK; on behalf of PROSPER Investigators Study Group. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial. Acta Neurol Scand. 2014;129:143-153.